SV Health Investors
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies
Mestag Therapeutics develops antibody treatments based on fibroblast immunology for cancer and inflammatory diseases. It is building therapies designed to direct and drive immune responses using fibroblast-immune biology.
Artios Pharma lands £90m Series D led by SV Health Investors and RA Capital Management to advance DNA damage response therapeutics
Artios Pharma develops cancer treatments that target DNA damage response pathways, focusing on patient groups with limited existing treatment options.
Alchemab Therapeutics raises £24m Series A extension led by Ono Venture Investment to advance AI-enabled antibody platform
Alchemab identifies naturally occurring protective antibodies using AI and patient data, developing new therapies based on disease resilience rather than traditional target discovery.
NRG Therapeutics lands £50m Series B led by SV Health Investors to advance neurodegenerative disease therapies
NRG Therapeutics develops oral small-molecule drugs targeting mitochondrial dysfunction, aiming to slow or halt neurodegenerative diseases such as ALS and Parkinson’s through disease-modifying treatments.
TRIMTECH raises £24m seed led by Cambridge Innovation Capital and SV Health Investors to advance neurodegenerative treatments
TRIMTECH Therapeutics develops targeted protein degradation medicines that selectively remove harmful protein aggregates, focusing on neurodegenerative and inflammatory diseases with limited existing treatment options.
More venture news
- 16 Apr 2026
OpenmooveOpenmoove lands £700k in funding led by Development Bank of Wales to streamline property transaction workflows
EquityProperty - 15 Apr 2026
The Little LoopThe Little Loop secures £750k in funding from The FSE Group for B2B2C clothing trade-in and resale platform
EquityCommerce - 15 Apr 2026
AscensionAscension secures £1.7m in funding from UKI2S and Innovate UK to tap geothermal critical mineral reserves
EquityIndustrial
